Background
Results
Model identification of neuropathic pain
Overview of lncRNAs and mRNA expression profiles after SNL
Differentially expressed lncRNAs and mRNAs
Up-regulated lncRNAs | Log2 fold change (SNL/sham) | P-value | Down-regulated lncRNAs | Log2 fold change (SNL/sham) | P-value |
---|---|---|---|---|---|
uc009egw.1
| 7,332.4243 | 7.07E−08 |
AK045739
| −45.320816 | 4.4E−09 |
Speer7-ps1
| 44.854053 | 3.44E−10 |
AK020832
| −17.557217 | 4.08E−09 |
MM9LINCRNAEXON12113+
| 28.60862 | 0.000138 |
AK047380
| −13.752911 | 0.0000278 |
ENSMUST00000118074
| 27.38603 | 0.0000454 |
ENSMUST00000171761
| −11.646089 | 7.18E−09 |
uc009nzx.1
| 26.05991 | 8.21E−06 |
uc008dwx.1
| −10.924568 | 0.00000859 |
ENSMUST00000165428
| 25.460197 | 0.0000126 |
AK134918
| −9.165875 | 0.02724757 |
CJ300890
| 23.606705 | 4.64E−06 |
ENSMUST00000160545
| −8.490716 | 0.0000666 |
MM9LINCRNAEXON11661+
| 20.514269 | 7.95E−08 |
AK013492
| −8.088422 | 0.000000162 |
CJ059670
| 19.443495 | 1.31E−07 |
MM9LINCRNAEXON10414− | −7.6248446 | 0.000158 |
NR_003548
| 18.795507 | 7.68E−08 |
CA874578
| −6.9701576 | 0.017664054 |
AK086225
| 17.855263 | 0.0000016 |
AK045554
| −6.809595 | 0.000000323 |
ENSMUST00000122927
| 15.532128 | 0.00000174 |
uc007cua.1
| −6.378551 | 0.0000552 |
ENSMUST00000150343
| 14.018134 | 0.00000125 |
NR_030776
| −5.654923 | 0.00000175 |
ENSMUST00000120145
| 13.556047 | 0.000000275 |
MM9LINCRNAEXON12090+
| −4.920551 | 0.000137 |
MM9LINCRNAEXON10692+
| 13.423789 | 0.00000243 |
MM9LINCRNAEXON10317+
| −4.7705894 | 0.00000728 |
ENSMUST00000121611
| 13.380642 | 0.00000161 |
uc007kom.1
| −4.603345 | 5.78E−09 |
humanlincRNA1606+
| 13.149129 | 0.0000756 |
ENSMUST00000134042
| −4.242255 | 0.0000337 |
AK085402
| 12.824574 | 0.000378 |
ENSMUST00000040306
| −4.188862 | 0.00000142 |
ENSMUST00000121062
| 12.615327 | 0.000000185 |
AK157618
| −4.0846663 | 0.000106 |
AK044525
| 12.42756 | 0.00000111 |
MM9LINCRNAEXON12066− | −4.066157 | 0.00000917 |
Gene symbol | Description | Log2 fold change (SNL/sham) |
P-value | |
---|---|---|---|---|
Up-regulated genes | ||||
Sprr1a
| Small proline-rich protein 1A | 148.7115 | 1.84E−10 | |
Anxa10
| Annexin A10 | 76.262054 | 1.61E−06 | |
4933402N22Rik
| RIKEN cDNA 4933402N22 gene | 46.512726 | 1.62E−10 | |
Vmn2r101
| Vomeronasal 2, receptor 101 | 44.090027 | 1.2E−08 | |
Kng1
| Kininogen 1 | 38.42939 | 2.14E−08 | |
Olfr803
| Olfactory receptor 803 | 31.403961 | 7.82E−08 | |
Gpr151
| G protein-coupled receptor 151 | 27.673513 | 5.95E−11 | |
LOC100048884
| Novel member of the major urinary protein (Mup) gene family | 24.719683 | 9.12E−09 | |
Mup11
| Major urinary protein 11 | 24.027332 | 8.26E−10 | |
Mup7
| Major urinary protein 7 | 23.950233 | 2.18E−08 | |
Mup12
| Major urinary protein 12 | 23.768707 | 2.79E−10 | |
Mup13
| Major urinary protein 13 | 23.234575 | 9.99E−08 | |
Mup19
| Major urinary proteins 11 and 8 | 23.019644 | 0.000000314 | |
Mup8
| Major urinary protein 8 | 22.686306 | 0.000000241 | |
Mup17
| Major urinary protein 17 | 21.82689 | 8.07E−10 | |
Atf3
| Activating transcription factor 3 | 19.8067 | 0.00000165 | |
Rreb1
| Ras responsive element binding protein 1 | 19.512457 | 0.0000258 | |
Olfr648
| Olfactory receptor 648 | 19.249556 | 0.00000434 | |
Clps
| Colipase, pancreatic | 18.952599 | 0.000000801 | |
Vax2
| Ventral anterior homeobox containing gene 2 | 17.30259 | 0.000187 | |
Down-regulated genes | ||||
Lefty1
| Left right determination factor 1 | −10.109003 | 0.000000123 | |
Olfr866
| Olfactory receptor 866 | −7.406356 | 0.011693356 | |
Kcna5
| Potassium voltage-gated channel, shaker-related subfamily, member 5 | −5.9395947 | 0.0000537 | |
Tnnt2
| Troponin T2, cardiac | −4.8715253 | 0.000213 | |
Csprs
| Component of Sp100-rs | −4.639864 | 0.000183 | |
Gm5458
| Predicted gene 5458 | −3.9395294 | 0.000162 | |
Ypel4
| Yippee-like 4 (Drosophila) | −3.8847303 | 0.0000976 | |
Sell
| Selectin, lymphocyte | −3.7625916 | 0.000967 | |
Mnx1
| Motor neuron and pancreas homeobox 1 | −3.702038 | 0.003540842 | |
Fnip1
| Folliculin interacting protein 1 | −3.4727607 | 0.000226 | |
Epm2a
| Epilepsy, progressive myoclonic epilepsy, type 2 gene alpha | −3.363634 | 0.00031 | |
H2-Ea-ps
| Histocompatibility 2, class II antigen E alpha, pseudogene | −3.2939498 | 0.000021 | |
Chodl
| Chondrolectin | −3.2821681 | 0.00000249 | |
Wtap
| Wilms’ tumour 1-associating protein | −3.1569881 | 0.0000001 | |
Pira4
| Paired-Ig-like receptor A4 | −3.1222947 | 0.03241746 | |
Eml4
| Echinoderm microtubule associated protein like 4 | −3.117333 | 0.020077666 | |
Tnnt2
| Troponin T2, cardiac | −3.0204759 | 0.0001 | |
Retnlg
| Resistin like gamma | −2.9266624 | 0.000000051 | |
Mmp8
| Matrix metallopeptidase 8 | −2.9234846 | 0.000255 |
Real-time quantitative PCR (qPCR) validation of lncRNA and mRNA expression
Class distribution of changed LncRNAs
Functional prediction of DE mRNAs in SNL
Comparison of our DE mRNAs with previously published microarrays
Relational analysis of lncRNAs and mRNAs
LncRNAs | Relationship | mRNAs | Function prediction of DE lncRNAs with related mRNAs | |||||
---|---|---|---|---|---|---|---|---|
Sequence name | Fold change | Regulation | GeneSymbol | Fold change | Regulation | Molecular Function | Pathway | |
ENSMUST00000160110
| 3.9130898 | Down | Antisense overlap |
Phtf1
| 2.1720073 | Down | GO:0003677 DNA binding | |
AK136749
| 2.089502 | Up | Antisense overlap |
Asap2
| 8.8652115 | Up | ||
ENSMUST00000121460
| 11.624642 | Up | Antisense overlap |
Mup2
| 16.324926 | Up | GO:0005215 transporter activity GO:0005550 pheromone binding | |
mouselincRNA1303+
| 2.959626 | Up | Intergenic |
Vmn1r54
| 2.5373068 | Up | ||
MM9LINCRNAEXON12110+
| 9.611986 | Up | Intergenic |
Apoa2
| 5.3063893 | Up | GO:0005319 lipid transporter activity GO:0008035 high-density lipoprotein binding GO:0017127 cholesterol transporter activity GO:0042803 protein homodimerization activity GO:0046982 protein heterodimerization activity GO:0055102 lipase inhibitor activity GO:0060228 phosphatidylcholine-sterol O-acyltransferase activator activity | PPAR signaling pathway |
MM9LINCRNAEXON11813−
| 2.2022471 | Up | Intergenic |
Ngfr
| 2.3073637 | Up | GO:0005030 neurotrophin receptor activity GO:0048406 nerve growth factor binding | Neurodegenerative disorders Cytokine–cytokine receptor interaction |
C75950
| 2.3177905 | Up | Intergenic |
Gm5136
| 2.2296717 | Down | ||
mouselincRNA1231−
| 2.3548565 | Up | Intergenic |
Hvcn1
| 2.0545347 | Up | GO:0005244 voltage-gated ion channel activity GO:0030171 voltage-gated proton channel activity | |
ENSMUST00000133243
| 2.2177694 | Up | Intergenic |
Uspl1
| 2.747246 | Up | GO:0004221 ubiquitin thiolesterase activity | |
MM9LINCRNAEXON11661+
| 20.514269 | Up | Intergenic |
Asap2
| 8.8652115 | Up | ||
humanlincRNA1070+
| 6.5686955 | Up | Intergenic |
Vax2
| 17.30259 | Up | GO:0003700 transcription factor activity | |
humanlincRNA2255−
| 6.4199057 | Up | Intergenic |
Trhr
| 2.1457152 | Down | ||
mouselincRNA1631+
| 2.131738 | Up | Intergenic |
Klhl15
| 2.0060081 | Up | GO:0005515 protein binding | |
humanlincRNA1443−
| 4.366208 | Up | Intergenic |
Igsf10
| 7.495438 | Up | GO:0005021 vascular endothelial growth factor receptor activity GO:0005515 protein binding GO:0005524 ATP binding | |
MM9LINCRNAEXON12110+
| 9.611986 | Up | Intergenic |
Dedd
| 2.2202826 | Down | GO:0003677 DNA binding GO:0005515 protein binding | |
MM9LINCRNAEXON10576−
| 5.209898 | Up | Intergenic |
Cxcl9
| 5.6018896 | Up | GO:0008009 chemokine activity | Cytokine–cytokine receptor interaction Toll-like receptor signaling pathway |
MM9LINCRNAEXON11308+
| 3.7596319 | Up | Intergenic |
Zfp654
| 2.1100945 | Down | GO:0003677 DNA binding GO:0008270 zinc ion binding | |
BM248967
| 6.0079184 | Up | Intergenic |
Dgkk
| 3.3316648 | Up | GO:0004143 diacylglycerol kinase activity | |
MM9LINCRNAEXON11616+
| 2.5639145 | Up | Intergenic |
Hexb
| 2.0003252 | Up | GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compounds GO:0004563 beta-N-acetylhexosaminidase activity GO:0042803 protein homodimerization activity GO:0043169 cation binding GO:0046982 protein heterodimerization activity |
N-Glycan degradation Aminosugars metabolism Glycosaminoglycan degradation Glycosphingolipid biosynthesis—globoseries Glycosphingolipid biosynthesis—ganglioseries Glycan structures—degradation |
uc008iab.1
| 2.1543121 | Down | Intergenic |
Fam160b1
| 2.5731633 | Up | ||
MM9LINCRNAEXON12066−
| 4.066157 | Down | Intergenic |
Tnnt2
| 3.0204759 | Down | GO:0005200 structural constituent of cytoskeleton | |
MM9LINCRNAEXON10576−
| 5.209898 | Up | Intergenic |
Cxcl11
| 2.7319772 | Up | GO:0008009 chemokine activity | Cytokine–cytokine receptor interaction Toll-like receptor signaling pathway |
MM9LINCRNAEXON10576−
| 5.209898 | Up | Intergenic |
Cxcl10
| 6.9877048 | Up | GO:0008009 chemokine activity | Cytokine–cytokine receptor interaction Toll-like receptor signaling pathway |
AK054438
| 2.3012707 | Up | Intergenic |
Ifi202b
| 9.431554 | Up | GO:0005515 protein binding | |
MM9LINCRNAEXON10268−
| 6.8239675 | Up | Intergenic |
Irf8
| 2.335659 | Up | GO:0003700 transcription factor activity | |
MM9LINCRNAEXON11735+
| 2.4868224 | Down | Intergenic |
Ppp2r5c
| 2.1656942 | Down | GO:0008601 protein phosphatase type 2A regulator activity | |
DV650983
| 2.0293975 | Down | Intergenic |
Olfr1416
| 2.2257524 | Up | GO:0004984 olfactory receptor activity | Olfactory transduction |
MM9LINCRNAEXON11795+
| 2.5727692 | Down | Intergenic |
Cd68
| 2.6843183 | Up | ||
MM9LINCRNAEXON11793+
| 2.671865 | Up | Intergenic |
Cd68
| 2.6843183 | Up | ||
ENSMUST00000120184
| 2.5531633 | Down | Sense overlap |
Amy2b
| 2.4439986 | Down | ||
uc007vpp.1
| 2.1796808 | Down | Sense overlap |
Trhr
| 2.1457152 | Down | GO:0004872 receptor activity GO:0004997 thyrotropin-releasing hormone receptor activity | Calcium signaling pathway Neuroactive ligand–receptor interaction |
uc009pmr.1
| 3.20246 | Down | Sense overlap |
Elmod1
| 2.2530112 | Down | ||
uc007cua.1
| 6.378551 | Down | Sense overlap |
Tnnt2
| 3.0204759 | Down | ||
ENSMUST00000040306
| 4.188862 | Down | Sense overlap |
H2-Ea-ps
| 3.2939498 | Down | ||
uc008uzw.1
| 2.2820547 | Up | Sense overlap |
Laptm5
| 2.1142242 | Up | ||
ENSMUST00000117412
| 2.5116289 | Up | Sense overlap |
Gm10147
| 2.2881203 | Up | ||
ENSMUST00000119882
| 3.1487308 | Up | Sense overlap |
Gm10486
| 2.4736855 | Up | ||
ENSMUST00000119882
| 3.1487308 | Up | Sense overlap |
Gm14819
| 3.018787 | Up | ||
uc008tbm.1
| 10.098583 | Up | Sense overlap |
Mup17
| 21.82689 | Up |
Discussion
Conclusion
Methods
Animals and surgery
Behavioral test
Immunohistochemistry
Tissue collection and RNA isolation
Microarray assay
Bioinformatics analysis
Real-time reverse transcription-polymerase chain reaction (RT-PCR)
Sequence name | Primer sequence | Amplicon size (bp) |
---|---|---|
Speer7-ps1
| F: 5′-CATGCTCTCATGCTCACCGA-3′ | 70 |
R: 5′-TACGCTGTAGGACCAGAACAC-3′ | ||
uc007pbc.1
| F: 5′-CATCTAGACCCGTAACGCCC-3′ | 340 |
R: 5′-TGGTAGGCAAGCATCCACAG-3′ | ||
ENSMUST00000171761
| F: 5’-TCGGAGACTTCTCTTCCGGT -3’ | 108 |
R: 5′-AAGACAATGCAGATGGGGCA-3′ | ||
ENSMUST00000097503
| F: 5′-AGGTCATCCCACTTTGGTACAC-3′ | 77 |
R: 5′-GAGTTTGGTTTGCGGGGTCT-3′ | ||
Cyp2d9
| F: 5′-TGTCTACCCTGCGCAACTTT-3′ | 71 |
F: 5′-GTGATTGGCCTCCTTGGTCA-3′ | ||
Mnx1
| F: 5′-GAACACCAGTTCAAGCTCAACA-3′ | 129 |
R: 5′-GCTGCGTTTCCATTTCATTCG-3′ | ||
Gapdh
| F:5′-TGTTCCTACCCCCAATGTG-3′ | 129 |
R:5′-GTGTAGCCCAAGATGCCCT-3′ |